首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes.
【2h】

Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes.

机译:地塞米松诱导的糖尿病中胰岛素抵抗和β细胞功能障碍的作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The roles of insulin resistance and beta-cell dysfunction in glucocorticoid-induced diabetes were determined in Wistar and Zucker (fa/fa) rats. All Wistar rats treated with 5 mg/kg per d of dexamethasone for 24 d exhibited increased beta-cell mass and basal and arginine-stimulated insulin secretion, indicating insulin resistance, but only 16% became diabetic. The insulin response to 20 mM glucose was normal in the perfused pancreas of all normoglycemic dexamethasone-treated rats but absent in every diabetic rat. Immunostainable high Km beta-cell transporter, GLUT-2, was present in approximately 100% of beta-cells of normoglycemic rats, but in only 25% of beta cells of diabetic rats. GLUT-2 mRNA was not reduced. All Zucker (fa/fa) rats treated with 0.2-0.4 mg/kg per d of dexamethasone for 24 d became diabetic and glucose-stimulated insulin secretion was absent in all. High Km glucose transport in islets was 50% below nondiabetic controls. Only 25% of beta cells of diabetic rats were GLUT-2-positive compared with approximately 100% in controls. Total pancreatic GLUT-2 mRNA was increased twofold suggesting a posttranscriptional abnormality. We conclude that dexamethasone induces insulin resistance, whether or not it induces hyperglycemia. Whenever hyperglycemia is present, GLUT-2-positive beta cells are reduced, high Km glucose transport into beta cells is attenuated and the insulin response to glucose is absent.
机译:在Wistar和Zucker(fa / fa)大鼠中确定了胰岛素抵抗和β细胞功能异常在糖皮质激素诱导的糖尿病中的作用。所有以每毫克每天5 mg / kg地塞米松治疗24天的Wistar大鼠均表现出增加的β细胞质量以及基础和精氨酸刺激的胰岛素分泌,表明胰岛素抵抗,但只有16%患有糖尿病。在所有经降糖地塞米松治疗的大鼠的灌注胰腺中,胰岛素对20 mM葡萄糖的反应正常,但在所有糖尿病大鼠中均不存在。高血糖的高Kmβ细胞转运蛋白GLUT-2存在于正常血糖大鼠的β细胞中约100%,而糖尿病大鼠的β细胞中只有25%。 GLUT-2 mRNA没有减少。所有每天每天接受0.2-0.4 mg / kg地塞米松治疗的Zucker(fa / fa)大鼠都患有糖尿病,并且全部缺乏葡萄糖刺激的胰岛素分泌。胰岛中的高Km葡萄糖转运比非糖尿病对照组低50%。糖尿病大鼠中只有25%的β细胞是GLUT-2阳性,而对照组中只有约100%。胰腺总GLUT-2 mRNA增加了两倍,表明转录后异常。我们得出的结论是,地塞米松会诱导胰岛素抵抗,无论它是否会引起高血糖症。每当出现高血糖症时,GLUT-2阳性β细胞都会减少,高Km葡萄糖向β细胞的转运会减弱,并且胰岛素对葡萄糖的反应也就不存在。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号